Acceleron Pharma Statistics Share Statistics Acceleron Pharma has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 1.35M, so 0% of the outstanding
shares have been sold short.
Short Interest 1.35M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.05
Valuation Ratios The PE ratio is -43.77 and the forward
PE ratio is null.
Acceleron Pharma's PEG ratio is
-1.93.
PE Ratio -43.77 Forward PE n/a PS Ratio 78.54 Forward PS n/a PB Ratio 8.5 P/FCF Ratio -54.02 PEG Ratio -1.93
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Acceleron Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 14.85,
with a Debt / Equity ratio of 0.03.
Current Ratio 14.85 Quick Ratio 14.85 Debt / Equity 0.03 Debt / EBITDA -0.15 Debt / FCF -0.18 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $296.55K Profits Per Employee $-532.15K Employee Count 312 Asset Turnover 0.1 Inventory Turnover n/a
Taxes Income Tax 21K Effective Tax Rate -0.01%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.13, so Acceleron Pharma's
price volatility has been higher than the market average.
Beta 0.13 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 1,265,302
Income Statement In the last 12 months, Acceleron Pharma had revenue of 92.52M
and earned -166.03M
in profits. Earnings per share was -2.92.
Revenue 92.52M Gross Profit 92.52M Operating Income -167.31M Net Income -166.03M EBITDA -162.16M EBIT -167.31M Earnings Per Share (EPS) -2.92
Full Income Statement Balance Sheet The company has 670.95M in cash and 24.08M in
debt, giving a net cash position of 646.88M.
Cash & Cash Equivalents 670.95M Total Debt 24.08M Net Cash 646.88M Retained Earnings -877.44M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -130.33M
and capital expenditures -4.2M, giving a free cash flow of -134.53M.
Operating Cash Flow -130.33M Capital Expenditures -4.2M Free Cash Flow -134.53M FCF Per Share -2.37
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -180.83% and -179.45%.
Gross Margin 100% Operating Margin -180.83% Pretax Margin -179.42% Profit Margin -179.45% EBITDA Margin -175.27% EBIT Margin -180.83% FCF Margin -145.4%
